Driven with perfection, we are engaged in catering to the needs of customers by bring a range of high quality product CAS NO 4604-41-5. The product 4604-41-5 is widely used in treating of congenital or drug-induced hypothyroidism in the developing human fetus. Our production process is beyond the industry standard. We adopt precise formulation, 3,5-Diiodo-L-tyrosinedihydrae CAS 4604-41-5 has strong action and effective.

Thera. Category: Treatment of hypothyroidism, myxedema and cretinism

Synonym: O-(4-hydroxy-3-iodophenyl)-3-iodo-L-tyrosine;3,5-Diiodo-L-tyrosinedihydrae;(S)-α-Amino-4-[(4-hydroxy-3-iodophenyl)oxy]-3-iodobenzenepropanoic acid;3-Iodo-O-(4-hydroxy-3-iodophenyl)-L-tyrosine;O-(3-Iodo-4-hydroxyphenyl)-3-iodo-L-tyrosine;3,3'-Diiodo-L-thyronine;(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3-iodophenyl]propanoic acid;(2S)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3-iodo-phenyl]propionic acid

Cas No.: 4604-41-5

Molecular Formula:C15H13I2NO4

Molecular Weight: 525.07696

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage: Intermediate

Related products:

1)CAS 51-48-9, L-Thyroxine

2)CAS 55-03-8, Levothyroxine sodium

3)CAS 55-06-1, Liothyronine sodium

4)CAS 1041-01-6, 3,5-Diiodo-L-thyronine

5)CAS 6893-02-3, 3,5,3`-triiodothyronine

6)CAS 5817-39-0, REVERSE T3

7)CAS 4604-41-5, 3,5-Diiodo-L-tyrosinedihydrae

8)CAS 300-39-0, 3,5-Diiodo-L-tyrosine dihydrate